Literature DB >> 31076311

Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology.

Patrick M Wieruszewski1, Charles R Sims2, Richard C Daly3, Timucin Taner4, Erica D Wittwer5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31076311     DOI： 10.1053/j.jvca.2019.03.054

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  2 in total

Review 1.  The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.

Authors:  Olga Papazisi; Meindert Palmen; A H Jan Danser
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-21       Impact factor: 3.947

2.  Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.

Authors:  Patrick M Wieruszewski; Erica D Wittwer; Kianoush B Kashani; Daniel R Brown; Simona O Butler; Angela M Clark; Craig J Cooper; Danielle L Davison; Ognjen Gajic; Kyle J Gunnerson; Rachel Tendler; Kristin C Mara; Erin F Barreto
Journal:  Chest       Date:  2020-08-31       Impact factor: 9.410
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.